The new inhaler will do a couple of things. Reduce cost and increase margin as it combines the carbon filter module within the unit and improves the packing density for freight.
It also reduces the complexity and time required to apply the active ingredient onto the evaporative media for inhalation. The changes are "equivalent in performance" so it should not impact existing medical efficacy or approval.
Ann: MVP Roadshow Presentation, page-8
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.0¢ |
Change
0.005(1.15%) |
Mkt cap ! $49.56M | |||
| Open | High | Low | Value | Volume |
| 43.5¢ | 45.0¢ | 43.0¢ | $72.64K | 164.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3355 | 44.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 15645 | 1 |
View Market Depth
| Last trade - 15.56pm 13/09/2024 (20 minute delay) ? |
| MVP (ASX) Chart |